Click for best price
Chronic Kidney Disease Drugs Market Size, Share 2024
| Market size in 2023 |
US$ 10260 million
|
Forecast Market size by 2030 |
US$ 12020 million
|
| Growth Rate |
CAGR of 1.9% |
Number of Pages |
116 Pages |
The global Chronic Kidney Disease Drugs market was valued at US$ 10260 million in 2023 and is projected to reach US$ 12020 million by 2030, at a CAGR of 1.9% during the forecast period.
The USA market for Global Chronic Kidney Disease Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Chronic Kidney Disease Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Chronic Kidney Disease Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This research report provides a comprehensive analysis of the Chronic Kidney Disease Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Chronic Kidney Disease Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Chronic Kidney Disease Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Chronic Kidney Disease Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Chronic Kidney Disease Drugs market presents opportunities for various stakeholders, including Hospitals, Specialty Clinics. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Chronic Kidney Disease Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Chronic Kidney Disease Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Chronic Kidney Disease Drugs market.
Market Overview: The report provides a comprehensive overview of the Chronic Kidney Disease Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., ACE Inhibitors, Calcium Channel Blockers), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Chronic Kidney Disease Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Chronic Kidney Disease Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Chronic Kidney Disease Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Chronic Kidney Disease Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Chronic Kidney Disease Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Chronic Kidney Disease Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Chronic Kidney Disease Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Chronic Kidney Disease Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Chronic Kidney Disease Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- ACE Inhibitors
- Calcium Channel Blockers
- Beta Blockers
- Others
Market segment by Application
- Hospitals
- Specialty Clinics
Global Chronic Kidney Disease Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- Keryx Biopharmaceuticals, Inc
- Kissei Pharmaceutical Co., Ltd
- AbbVie
- GlaxoSmithKline
- Sanofi
- F. Hoffmann-La Roche Ltd
- Pfizer
- AstraZeneca
- Amgen
- Teva Pharmaceutical Industries
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chronic Kidney Disease Drugs, market overview.
Chapter 2: Global Chronic Kidney Disease Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Chronic Kidney Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chronic Kidney Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Chronic Kidney Disease Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Chronic Kidney Disease Drugs Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 10260 million
|
| Forecast Market size by 2030 |
US$ 12020 million
|
| Growth Rate |
CAGR of 1.9% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
116 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chronic Kidney Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Kidney Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Kidney Disease Drugs Overall Market Size
2.1 Global Chronic Kidney Disease Drugs Market Size: 2023 VS 2030
2.2 Global Chronic Kidney Disease Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Chronic Kidney Disease Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Chronic Kidney Disease Drugs Players in Global Market
3.2 Top Global Chronic Kidney Disease Drugs Companies Ranked by Revenue
3.3 Global Chronic Kidney Disease Drugs Revenue by Companies
3.4 Global Chronic Kidney Disease Drugs Sales by Companies
3.5 Global Chronic Kidney Disease Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Chronic Kidney Disease Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Chronic Kidney Disease Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chronic Kidney Disease Drugs Players in Global Market
3.8.1 List of Global Tier 1 Chronic Kidney Disease Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Kidney Disease Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Chronic Kidney Disease Drugs Market Size Markets, 2023 & 2030
4.1.2 ACE Inhibitors
4.1.3 Calcium Channel Blockers
4.1.4 Beta Blockers
4.1.5 Others
4.2 By Type - Global Chronic Kidney Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Chronic Kidney Disease Drugs Revenue, 2019-2024
4.2.2 By Type - Global Chronic Kidney Disease Drugs Revenue, 2025-2030
4.2.3 By Type - Global Chronic Kidney Disease Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Chronic Kidney Disease Drugs Sales & Forecasts
4.3.1 By Type - Global Chronic Kidney Disease Drugs Sales, 2019-2024
4.3.2 By Type - Global Chronic Kidney Disease Drugs Sales, 2025-2030
4.3.3 By Type - Global Chronic Kidney Disease Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Chronic Kidney Disease Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chronic Kidney Disease Drugs Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.2 By Application - Global Chronic Kidney Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Chronic Kidney Disease Drugs Revenue, 2019-2024
5.2.2 By Application - Global Chronic Kidney Disease Drugs Revenue, 2025-2030
5.2.3 By Application - Global Chronic Kidney Disease Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Chronic Kidney Disease Drugs Sales & Forecasts
5.3.1 By Application - Global Chronic Kidney Disease Drugs Sales, 2019-2024
5.3.2 By Application - Global Chronic Kidney Disease Drugs Sales, 2025-2030
5.3.3 By Application - Global Chronic Kidney Disease Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Chronic Kidney Disease Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Chronic Kidney Disease Drugs Market Size, 2023 & 2030
6.2 By Region - Global Chronic Kidney Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Chronic Kidney Disease Drugs Revenue, 2019-2024
6.2.2 By Region - Global Chronic Kidney Disease Drugs Revenue, 2025-2030
6.2.3 By Region - Global Chronic Kidney Disease Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Chronic Kidney Disease Drugs Sales & Forecasts
6.3.1 By Region - Global Chronic Kidney Disease Drugs Sales, 2019-2024
6.3.2 By Region - Global Chronic Kidney Disease Drugs Sales, 2025-2030
6.3.3 By Region - Global Chronic Kidney Disease Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Chronic Kidney Disease Drugs Revenue, 2019-2030
6.4.2 By Country - North America Chronic Kidney Disease Drugs Sales, 2019-2030
6.4.3 US Chronic Kidney Disease Drugs Market Size, 2019-2030
6.4.4 Canada Chronic Kidney Disease Drugs Market Size, 2019-2030
6.4.5 Mexico Chronic Kidney Disease Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Chronic Kidney Disease Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Chronic Kidney Disease Drugs Sales, 2019-2030
6.5.3 Germany Chronic Kidney Disease Drugs Market Size, 2019-2030
6.5.4 France Chronic Kidney Disease Drugs Market Size, 2019-2030
6.5.5 U.K. Chronic Kidney Disease Drugs Market Size, 2019-2030
6.5.6 Italy Chronic Kidney Disease Drugs Market Size, 2019-2030
6.5.7 Russia Chronic Kidney Disease Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Chronic Kidney Disease Drugs Market Size, 2019-2030
6.5.9 Benelux Chronic Kidney Disease Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Chronic Kidney Disease Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Chronic Kidney Disease Drugs Sales, 2019-2030
6.6.3 China Chronic Kidney Disease Drugs Market Size, 2019-2030
6.6.4 Japan Chronic Kidney Disease Drugs Market Size, 2019-2030
6.6.5 South Korea Chronic Kidney Disease Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Chronic Kidney Disease Drugs Market Size, 2019-2030
6.6.7 India Chronic Kidney Disease Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Chronic Kidney Disease Drugs Revenue, 2019-2030
6.7.2 By Country - South America Chronic Kidney Disease Drugs Sales, 2019-2030
6.7.3 Brazil Chronic Kidney Disease Drugs Market Size, 2019-2030
6.7.4 Argentina Chronic Kidney Disease Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chronic Kidney Disease Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Chronic Kidney Disease Drugs Sales, 2019-2030
6.8.3 Turkey Chronic Kidney Disease Drugs Market Size, 2019-2030
6.8.4 Israel Chronic Kidney Disease Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Chronic Kidney Disease Drugs Market Size, 2019-2030
6.8.6 UAE Chronic Kidney Disease Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Keryx Biopharmaceuticals, Inc
7.1.1 Keryx Biopharmaceuticals, Inc Company Summary
7.1.2 Keryx Biopharmaceuticals, Inc Business Overview
7.1.3 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Major Product Offerings
7.1.4 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Keryx Biopharmaceuticals, Inc Key News & Latest Developments
7.2 Kissei Pharmaceutical Co., Ltd
7.2.1 Kissei Pharmaceutical Co., Ltd Company Summary
7.2.2 Kissei Pharmaceutical Co., Ltd Business Overview
7.2.3 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Major Product Offerings
7.2.4 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales and Revenue in Global (2019-2024)
7.2.5 Kissei Pharmaceutical Co., Ltd Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Chronic Kidney Disease Drugs Major Product Offerings
7.3.4 AbbVie Chronic Kidney Disease Drugs Sales and Revenue in Global (2019-2024)
7.3.5 AbbVie Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Chronic Kidney Disease Drugs Major Product Offerings
7.4.4 GlaxoSmithKline Chronic Kidney Disease Drugs Sales and Revenue in Global (2019-2024)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Chronic Kidney Disease Drugs Major Product Offerings
7.5.4 Sanofi Chronic Kidney Disease Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Sanofi Key News & Latest Developments
7.6 F. Hoffmann-La Roche Ltd
7.6.1 F. Hoffmann-La Roche Ltd Company Summary
7.6.2 F. Hoffmann-La Roche Ltd Business Overview
7.6.3 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Major Product Offerings
7.6.4 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales and Revenue in Global (2019-2024)
7.6.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Chronic Kidney Disease Drugs Major Product Offerings
7.7.4 Pfizer Chronic Kidney Disease Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Pfizer Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Chronic Kidney Disease Drugs Major Product Offerings
7.8.4 AstraZeneca Chronic Kidney Disease Drugs Sales and Revenue in Global (2019-2024)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Amgen
7.9.1 Amgen Company Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Chronic Kidney Disease Drugs Major Product Offerings
7.9.4 Amgen Chronic Kidney Disease Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Amgen Key News & Latest Developments
7.10 Teva Pharmaceutical Industries
7.10.1 Teva Pharmaceutical Industries Company Summary
7.10.2 Teva Pharmaceutical Industries Business Overview
7.10.3 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Teva Pharmaceutical Industries Key News & Latest Developments
8 Global Chronic Kidney Disease Drugs Production Capacity, Analysis
8.1 Global Chronic Kidney Disease Drugs Production Capacity, 2019-2030
8.2 Chronic Kidney Disease Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Kidney Disease Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chronic Kidney Disease Drugs Supply Chain Analysis
10.1 Chronic Kidney Disease Drugs Industry Value Chain
10.2 Chronic Kidney Disease Drugs Upstream Market
10.3 Chronic Kidney Disease Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Kidney Disease Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Chronic Kidney Disease Drugs in Global Market
Table 2. Top Chronic Kidney Disease Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Chronic Kidney Disease Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Chronic Kidney Disease Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Chronic Kidney Disease Drugs Sales by Companies, (K MT), 2019-2024
Table 6. Global Chronic Kidney Disease Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Chronic Kidney Disease Drugs Price (2019-2024) & (USD/MT)
Table 8. Global Manufacturers Chronic Kidney Disease Drugs Product Type
Table 9. List of Global Tier 1 Chronic Kidney Disease Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Kidney Disease Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Chronic Kidney Disease Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Chronic Kidney Disease Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Chronic Kidney Disease Drugs Sales (K MT), 2019-2024
Table 15. By Type - Global Chronic Kidney Disease Drugs Sales (K MT), 2025-2030
Table 16. By Application ? Global Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Chronic Kidney Disease Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Chronic Kidney Disease Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Chronic Kidney Disease Drugs Sales (K MT), 2019-2024
Table 20. By Application - Global Chronic Kidney Disease Drugs Sales (K MT), 2025-2030
Table 21. By Region ? Global Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Chronic Kidney Disease Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Chronic Kidney Disease Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Chronic Kidney Disease Drugs Sales (K MT), 2019-2024
Table 25. By Region - Global Chronic Kidney Disease Drugs Sales (K MT), 2025-2030
Table 26. By Country - North America Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Chronic Kidney Disease Drugs Sales, (K MT), 2019-2024
Table 29. By Country - North America Chronic Kidney Disease Drugs Sales, (K MT), 2025-2030
Table 30. By Country - Europe Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Chronic Kidney Disease Drugs Sales, (K MT), 2019-2024
Table 33. By Country - Europe Chronic Kidney Disease Drugs Sales, (K MT), 2025-2030
Table 34. By Region - Asia Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Chronic Kidney Disease Drugs Sales, (K MT), 2019-2024
Table 37. By Region - Asia Chronic Kidney Disease Drugs Sales, (K MT), 2025-2030
Table 38. By Country - South America Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Chronic Kidney Disease Drugs Sales, (K MT), 2019-2024
Table 41. By Country - South America Chronic Kidney Disease Drugs Sales, (K MT), 2025-2030
Table 42. By Country - Middle East & Africa Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Chronic Kidney Disease Drugs Sales, (K MT), 2019-2024
Table 45. By Country - Middle East & Africa Chronic Kidney Disease Drugs Sales, (K MT), 2025-2030
Table 46. Keryx Biopharmaceuticals, Inc Company Summary
Table 47. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Product Offerings
Table 48. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 49. Keryx Biopharmaceuticals, Inc Key News & Latest Developments
Table 50. Kissei Pharmaceutical Co., Ltd Company Summary
Table 51. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Product Offerings
Table 52. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 53. Kissei Pharmaceutical Co., Ltd Key News & Latest Developments
Table 54. AbbVie Company Summary
Table 55. AbbVie Chronic Kidney Disease Drugs Product Offerings
Table 56. AbbVie Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 57. AbbVie Key News & Latest Developments
Table 58. GlaxoSmithKline Company Summary
Table 59. GlaxoSmithKline Chronic Kidney Disease Drugs Product Offerings
Table 60. GlaxoSmithKline Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 61. GlaxoSmithKline Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Chronic Kidney Disease Drugs Product Offerings
Table 64. Sanofi Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 65. Sanofi Key News & Latest Developments
Table 66. F. Hoffmann-La Roche Ltd Company Summary
Table 67. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Product Offerings
Table 68. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 69. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Chronic Kidney Disease Drugs Product Offerings
Table 72. Pfizer Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 73. Pfizer Key News & Latest Developments
Table 74. AstraZeneca Company Summary
Table 75. AstraZeneca Chronic Kidney Disease Drugs Product Offerings
Table 76. AstraZeneca Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 77. AstraZeneca Key News & Latest Developments
Table 78. Amgen Company Summary
Table 79. Amgen Chronic Kidney Disease Drugs Product Offerings
Table 80. Amgen Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 81. Amgen Key News & Latest Developments
Table 82. Teva Pharmaceutical Industries Company Summary
Table 83. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Product Offerings
Table 84. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 85. Teva Pharmaceutical Industries Key News & Latest Developments
Table 86. Chronic Kidney Disease Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2022-2024 (K MT)
Table 87. Global Chronic Kidney Disease Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 88. Global Chronic Kidney Disease Drugs Production by Region, 2019-2024 (K MT)
Table 89. Global Chronic Kidney Disease Drugs Production by Region, 2025-2030 (K MT)
Table 90. Chronic Kidney Disease Drugs Market Opportunities & Trends in Global Market
Table 91. Chronic Kidney Disease Drugs Market Drivers in Global Market
Table 92. Chronic Kidney Disease Drugs Market Restraints in Global Market
Table 93. Chronic Kidney Disease Drugs Raw Materials
Table 94. Chronic Kidney Disease Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Chronic Kidney Disease Drugs Downstream
Table 96. Chronic Kidney Disease Drugs Downstream Clients in Global Market
Table 97. Chronic Kidney Disease Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Chronic Kidney Disease Drugs Segment by Type in 2023
Figure 2. Chronic Kidney Disease Drugs Segment by Application in 2023
Figure 3. Global Chronic Kidney Disease Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Chronic Kidney Disease Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Chronic Kidney Disease Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Chronic Kidney Disease Drugs Sales in Global Market: 2019-2030 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Chronic Kidney Disease Drugs Revenue in 2023
Figure 9. By Type - Global Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Chronic Kidney Disease Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Chronic Kidney Disease Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Chronic Kidney Disease Drugs Price (USD/MT), 2019-2030
Figure 13. By Application - Global Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Chronic Kidney Disease Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Chronic Kidney Disease Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Chronic Kidney Disease Drugs Price (USD/MT), 2019-2030
Figure 17. By Region - Global Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Chronic Kidney Disease Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Chronic Kidney Disease Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Chronic Kidney Disease Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Chronic Kidney Disease Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Chronic Kidney Disease Drugs Sales Market Share, 2019-2030
Figure 23. US Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Chronic Kidney Disease Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Chronic Kidney Disease Drugs Sales Market Share, 2019-2030
Figure 28. Germany Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Chronic Kidney Disease Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Chronic Kidney Disease Drugs Sales Market Share, 2019-2030
Figure 37. China Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Chronic Kidney Disease Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Chronic Kidney Disease Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Chronic Kidney Disease Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Chronic Kidney Disease Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Chronic Kidney Disease Drugs Production Capacity (K MT), 2019-2030
Figure 53. The Percentage of Production Chronic Kidney Disease Drugs by Region, 2023 VS 2030
Figure 54. Chronic Kidney Disease Drugs Industry Value Chain
Figure 55. Marketing Channels
